BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Adipose tissue
,
Avian flu virus
,
Tamoxifen
,
rs3825942
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
transmembrane receptor protein kinase activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Melanocytes with inducible oncogenic receptor Xmrk stimulated with EGF
Epithelial colon cancer Ls174T cells inducibly expressing WT TGFBR2 treated with human TGF-beta1
Differential Cardiac Gene Regulation by Polymorphic Forms of the b1-adrenergic Receptor
Thrombocyte miRNA expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
Transforming growth factor beta signaling mediators and modulators.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of TACI(Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interact…
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Tr…
Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-…
Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ